Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)
837.58 x 1 845.00 x 1
Post-market by (Cboe BZX)
842.57 +5.56 (+0.66%) 03/20/25 [NYSE]
837.58 x 1 845.00 x 1
Post-market 842.53 -0.04 (-0.00%) 19:03 ET
Quote Overview for Thu, Mar 20th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
832.46
Day High
854.39
Open 839.03
Previous Close 837.01 837.01
Volume 4,402,700 4,402,700
Avg Vol 3,665,935 3,665,935
Stochastic %K 27.56% 27.56%
Weighted Alpha +6.36 +6.36
5-Day Change +40.92 (+5.10%) +40.92 (+5.10%)
52-Week Range 711.40 - 972.53 711.40 - 972.53
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 798,899,584
  • Shares Outstanding, K 948,170
  • Annual Sales, $ 45,043 M
  • Annual Income, $ 10,590 M
  • EBIT $ 12,899 M
  • EBITDA $ 14,666 M
  • 60-Month Beta 0.34
  • Price/Sales 17.62
  • Price/Cash Flow 57.78
  • Price/Book 54.71

Options Overview Details

View History
  • Implied Volatility 29.37% ( -0.70%)
  • Historical Volatility 30.79%
  • IV Percentile 40%
  • IV Rank 21.17%
  • IV High 55.08% on 08/05/24
  • IV Low 22.46% on 06/28/24
  • Put/Call Vol Ratio 0.64
  • Today's Volume 30,130
  • Volume Avg (30-Day) 40,675
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 281,780
  • Open Int (30-Day) 279,042

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 4.60
  • Number of Estimates 9
  • High Estimate 5.36
  • Low Estimate 4.20
  • Prior Year 2.58
  • Growth Rate Est. (year over year) +78.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
795.38 +5.93%
on 03/13/25
Period Open: 873.12
935.63 -9.95%
on 03/03/25
-30.55 (-3.50%)
since 02/20/25
3-Month
725.01 +16.21%
on 01/17/25
Period Open: 767.76
935.63 -9.95%
on 03/03/25
+74.81 (+9.74%)
since 12/20/24
52-Week
711.40 +18.44%
on 11/18/24
Period Open: 772.86
972.53 -13.36%
on 08/22/24
+69.71 (+9.02%)
since 03/20/24

Most Recent Stories

More News
GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below. The stock has...

NVO : 78.79 (-0.27%)
LLY : 842.57 (+0.66%)
HLN : 10.39 (+0.19%)
GSK : 39.41 (-0.35%)
5 Reasons It's Not Too Late to Buy Eli Lilly Stock

Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable healthcare company in the world, with a market cap of $730 billion.

LLY : 842.57 (+0.66%)
UNH : 511.30 (+1.61%)
3 Market-Beating Stocks to Target This Week

3 Market-Beating Stocks to Target This Week

GVA : 76.25 (+0.40%)
LLY : 842.57 (+0.66%)
HUBB : 339.18 (-0.89%)
Why Novo Nordisk Stock Outpaced the Market on Tuesday

Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little on the stock exchange Tuesday. The company was one of the rare enterprises seeing an increase...

NVO : 78.79 (-0.27%)
$SPX : 5,662.89 (-0.22%)
UBS : 32.99 (-0.24%)
LLY : 842.57 (+0.66%)
Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Amgen’s AMGN stock has risen 21.7% so far this year compared with an increase of 7% for the industry.AMGN Stock PerformanceImage Source: Zacks Investment ResearchAmgen’s stock has been rising consistently,...

NVO : 78.79 (-0.27%)
LLY : 842.57 (+0.66%)
ABBV : 211.96 (-0.14%)
AMGN : 315.04 (-0.22%)
Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.

VKTX : 28.35 (-5.72%)
NVO : 78.79 (-0.27%)
HIMS : 32.87 (-2.98%)
LLY : 842.57 (+0.66%)
BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market

/CNW/ - Join BMO and industry leaders in New York on March 25 for the BMO 2025 Obesity Summit to discuss the growing $150 billion obesity therapies market. The...

LLY : 842.57 (+0.66%)
Why Hims & Hers Stock Popped on Monday

Morgan Stanley had great news for Hims & Hers stock today, so why didn't it upgrade the stock?

AAPL : 214.10 (-0.53%)
HIMS : 32.87 (-2.98%)
NVO : 78.79 (-0.27%)
MS : 120.47 (+0.52%)
LLY : 842.57 (+0.66%)
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility .

NVO : 78.79 (-0.27%)
VRTX : 510.18 (-0.46%)
LLY : 842.57 (+0.66%)
3 Healthcare Stocks with Exciting Potential

3 Healthcare Stocks with Exciting Potential

OPCH : 34.29 (-0.67%)
LLY : 842.57 (+0.66%)
THC : 126.34 (-1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 875.74
2nd Resistance Point 865.07
1st Resistance Point 853.82
Last Price 842.57
1st Support Level 831.89
2nd Support Level 821.22
3rd Support Level 809.97

See More

52-Week High 972.53
Fibonacci 61.8% 872.78
Last Price 842.57
Fibonacci 50% 841.97
Fibonacci 38.2% 811.15
52-Week Low 711.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals